Lung Cancer

1

Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report

Mellema, Wouter W., Burgers, Sjaak A., Smit, Egbert. F.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 749 KB

english, 2015

2

Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing

Jurmeister, Philipp, Lenze, Dido, Berg, Erika, Mende, Stefanie, Schäper, Frank, Kellner, Udo, Herbst, Hermann, Sers, Christine, Budczies, Jan, Dietel, Manfred, Hummel, Michael, von Laffert, Maximilian

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.17 MB

english, 2015

3

The impact of comorbidity upon determinants of outcome in patients with lung cancer

Grose, Derek, Morrison, David S., Devereux, Graham, Jones, Richard, Sharma, Dave, Selby, Colin, Docherty, Kirsty, McIntosh, David, Nicolson, Marianne, McMillan, Donald C., Milroy, Robert

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 644 KB

english, 2015

4

Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma

Zhao, Mingchuan, Zhang, Yishi, Zhang, Huijun, Wang, Shaohua, Zhang, Mengmeng, Chen, Xi, Wang, Heyong, Zeng, Gang, Chen, Xiaofeng, Liu, Gentao, Zhou, Caicun

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.80 MB

english, 2015

5

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

Arrieta, Oscar, Cardona, Andrés Felipe, Corrales, Luis, Campos-Parra, Alma Delia, Sánchez-Reyes, Roberto, Amieva-Rivera, Eduardo, Rodríguez, July, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Karac

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 819 KB

english, 2015

6

Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung

Qiong, Zhao, Na, Wang Yi, Bo, Wang, Zhu, Zeng, Ling, Peng, Bo, Mou Hai, Min, Tang Ye, Lei, Zeng, Na, Hu Dan, Bo, Zhao, Fang, Liu Jun, Seng, Zheng Shu

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 560 KB

english, 2015

7

Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer

Guo, Xu, Li, Deyang, Wu, Yousheng, Chen, Yibing, Zhou, Xingchun, Wang, Xiaoyan, Huang, Xiaojun, Li, Xiaofei, Yang, Hushan, Xing, Jinliang

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 996 KB

english, 2015

8

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501

Nogami, Naoyuki, Takigawa, Nagio, Hotta, Katsuyuki, Segawa, Yoshihiko, Kato, Yuka, Kozuki, Toshiyuki, Oze, Isao, Kishino, Daizo, Aoe, Keisuke, Ueoka, Hiroshi, Kuyama, Shoichi, Harita, Shingo, Okada, T

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 816 KB

english, 2015

9

A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109)

Hattori, Yoshihiro, Satouchi, Miyako, Shimada, Temiko, Urata, Yoshiko, Yoneda, Tsutomu, Mori, Masahide, Nishimura, Takashi, Sunadome, Hironobu, Kumagai, Toru, Imamura, Fumio, Fujita, Shiro, Kaji, Reik

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 484 KB

english, 2015

10

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea

Baek, Jin Ho, Sun, Jong-Mu, Min, Young Joo, Cho, Eun Kyung, Cho, Byoung Chul, Kim, Joo-Hang, Ahn, Myung-Ju, Park, Keunchil

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 664 KB

english, 2015

11

Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?

Choi, Yong Won, Ahn, Mi Sun, Jeong, Geum Sook, Lee, Hyun Woo, Jeong, Seong Hyun, Kang, Seok Yun, Park, Joon Seong, Choi, Jin-Hyuk, Lee, Soon Young

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 576 KB

english, 2015

12

Quantification and consequences of lung cancer CT overdiagnosis

Reich, Jerome M., Kim, Jong S.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 165 KB

english, 2015

13

Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer

Drzewiecka, Hanna, Gałęcki, Bartłomiej, Jarmołowska-Jurczyszyn, Donata, Kluk, Andrzej, Dyszkiewicz, Wojciech, Jagodziński, Paweł P.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.57 MB

english, 2015

14

Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer

Davis, Keith L., Goyal, Ravi K., Able, Stephen L., Brown, Jacqueline, Li, Li, Kaye, James A.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 692 KB

english, 2015

15

Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient

Lu, Stephanie, Azada, Michele C., Ou, Sai-Hong Ignatius

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.08 MB

english, 2015

16

Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry

Kocher, Florian, Hilbe, Wolfgang, Seeber, Andreas, Pircher, Andreas, Schmid, Thomas, Greil, Richard, Auberger, Jutta, Nevinny-Stickel, Meinhard, Sterlacci, William, Tzankov, Alexandar, Jamnig, Herbert

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.18 MB

english, 2015

17

Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]

Auliac, J.B., Chouaid, C., Greillier, L., Monnet, I., Le Caer, H., Falchero, L., Corre, R., Descourt, R., Bota, S., Berard, H., Schott, R., Bizieux, A., Fournel, P., Labrunie, A., Marin, B., Vergneneg

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 126 KB

english, 2015

18

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus

Cappuzzo, Federico, Moro-Sibilot, Denis, Gautschi, Oliver, Boleti, Ekaterini, Felip, Enriqueta, Groen, Harry J.M., Germonpré, Paul, Meldgaard, Peter, Arriola, Edurne, Steele, Nicola, Fox, Jesme, Schne

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 942 KB

english, 2015

19

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

Tiseo, Marcello, Bersanelli, Melissa, Perrone, Federica, Tamborini, Elena, Settanni, Giulio, Busico, Adele, Rossi, Giulio, Ardizzoni, Andrea, Pelosi, Giuseppe

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.37 MB

english, 2015

20

Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status

Walasek, Tomasz, Sas-Korczyńska, Beata, Dąbrowski, Tomasz, Reinfuss, Marian, Jakubowicz, Jerzy, Blecharz, Paweł, Łuczyńska, Elżbieta, Darasz, Zbigniew, Skotnicki, Piotr

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 609 KB

english, 2015

22

Editorial Board

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 69 KB

english, 2015

Volume 87; Issue 2

Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report

Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing

The impact of comorbidity upon determinants of outcome in patients with lung cancer

Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung

Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501

A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109)

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea

Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?

Quantification and consequences of lung cancer CT overdiagnosis

Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer

Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer

Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient

Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry

Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

Contents

Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status

Editorial Board